Beiser AS - Search Results

1

Associations of cerebral amyloid beta and tau with cognition from midlife.

Gonzales MM, O'Donnell A, Ghosh S, Thibault E, Tanner J, Satizabal CL, Decarli CS, Fakhri GE, Johnson KA, Beiser AS, Seshadri S, Pase M. Gonzales MM, et al. Among authors: beiser as. Alzheimers Dement. 2024 Sep;20(9):5901-5911. doi: 10.1002/alz.14060. Epub 2024 Jul 22. Alzheimers Dement. 2024. PMID: 39039896 Free PMC article.

2

Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.

Seshadri S, Wolf PA, Beiser A, Au R, McNulty K, White R, D'Agostino RB. Seshadri S, et al. Neurology. 1997 Dec;49(6):1498-504. doi: 10.1212/wnl.49.6.1498. Neurology. 1997. PMID: 9409336

3

Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

Beiser A, D'Agostino RB Sr, Seshadri S, Sullivan LM, Wolf PA. Beiser A, et al. Stat Med. 2000 Jun 15-30;19(11-12):1495-522. doi: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1495::aid-sim441>3.0.co;2-e. Stat Med. 2000. PMID: 10844714

4

Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study.

Seshadri S, Wolf PA, Beiser A, Vasan RS, Wilson PW, Kase CS, Kelly-Hayes M, Kannel WB, D'Agostino RB. Seshadri S, et al. Arch Intern Med. 2001 Oct 22;161(19):2343-50. doi: 10.1001/archinte.161.19.2343. Arch Intern Med. 2001. PMID: 11606150

5

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Seshadri S, et al. N Engl J Med. 2002 Feb 14;346(7):476-83. doi: 10.1056/NEJMoa011613. N Engl J Med. 2002. PMID: 11844848 Free article.

6

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study.

Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Vasan RS, et al. JAMA. 2002 Feb 27;287(8):1003-10. doi: 10.1001/jama.287.8.1003. JAMA. 2002. PMID: 11866648

7

Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study.

Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA. Tan ZS, et al. Arch Intern Med. 2003 May 12;163(9):1053-7. doi: 10.1001/archinte.163.9.1053. Arch Intern Med. 2003. PMID: 12742802

8

Framingham stroke risk profile and lowered cognitive performance.

Elias MF, Sullivan LM, D'Agostino RB, Elias PK, Beiser A, Au R, Seshadri S, DeCarli C, Wolf PA. Elias MF, et al. Stroke. 2004 Feb;35(2):404-9. doi: 10.1161/01.STR.0000103141.82869.77. Epub 2004 Jan 15. Stroke. 2004. PMID: 14726556

9

Dementia after stroke: the Framingham Study.

Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Ivan CS, et al. Stroke. 2004 Jun;35(6):1264-8. doi: 10.1161/01.STR.0000127810.92616.78. Epub 2004 Apr 29. Stroke. 2004. PMID: 15118167

10

Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study.

Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, Massaro JM, DeCarli C. Jeerakathil T, et al. Stroke. 2004 Aug;35(8):1831-5. doi: 10.1161/01.STR.0000131809.35202.1b. Epub 2004 May 20. Stroke. 2004. PMID: 15155954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters